<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

1 min read

Before AVA: Preventing Peripheral IV Failure

9/30/19 10:17 AM

ST Las VegasSmartTRAK is excited to be attending the #AVA Association for Vascular Access 2019 Annual Scientific Meeting taking place October 4-7, 2019 at Caesars Palace in Las Vegas, NV.

Susan Paquette, Vice President and General Manager, Wound, will be representing SmartTRAK at AVA.


Susan has been with SmartTRAK since 2011, leading the Wound efforts. Prior to SmartTRAK, Susan was with 3M for 20+ years' holding leadership positions in new business development, R&D, international and marketing. 

If you would like to meet with Susan for SmartTRAK's insights into the Vascular Access market at #AVA2019, please click to schedule a meeting. To read a SmartTRAK Market Outlook article Susan wrote "Preventing Peripheral IV Failure: The Next Big Thing in Vascular Access" following AVA 2018, click below...

Following AVA 2018, Susan wrote a fascinating Market Outlook article "Preventing Peripheral IV Failure: The Next Big Thing in Vascular Access". In that article Susan explored what’s next for peripheral IVs, estimating that products that prevent peripheral IV failure represent a market opportunity valued at more than $600MM in the US alone. She also discusses what’s next in the space and who to watch out for. If you would like to download and read that article in it's entirety, you can download it by clicking the button below.

Download our Vascular Access article now!


Topics: Wound Care

Lindsey Wolejko
Written by Lindsey Wolejko

Senior Director Commerical Marketing. 12+ years experience in marketing and branding with a strong focus on healthcare and finance. Roles in Account Management and Brand Strategy with the likes of Ogilvy and Connecticut's top shop, Cronin. MBA in consulting from the University of Connecticut's School of Business.

    Recent Articles